참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | N,N-Dimethyl-1,3-propanediamine | HCID 7993 | — |
| 반응물 | 1-Hydroxybenzotriazole | HCID 75771 | — |
| 반응물 | N-[(Phenylmethoxy)carbonyl]-L-isoleucine 4-nitrophenyl ester | HCID 2063382 | — |
| 반응물 | Prolyl-proline hydrobromide | HCID 68145334 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Triethylamine | HCID 8471 | — |
| 생성물 | Benzyloxycarbonyl-isoleucyl-proline proline | HCID 68146244 | 240.9% |
반응 단계
Prolyl-proline hydrobromide (4.24 g) is dissolved in a mixture of dimethylformamide (40 ml) and triethylamine (2.8 ml). Benzyloxycarbonyl-isoleucine p-nitrophenyl ester (9.27 g) and 1-hydroxybenzotriazole (3 g) are added and the mixture is stored at room temperature for 16 hours. Dimethylaminopropylamine (1 ml) is added and after 2 hours the solvent is removed in vacuo. The residue is dissolved in ethyl acetate (200 ml) and washed sequentially with 0.1 N hydrochloric acid, and water. The organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo to yield 13.8 g solid. This material is applied to a silica gel column (300 g) in ethyl acetate and eluted with the same solvent. The fractions containing the desired above-titled tripeptide are pooled and concentrated to dryness.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US03973006 |
|---|
| 출처 데이터셋 | uspto-grants-1976_08 |
|---|
| ORD ID | ord-8f539f9468b14564a0c78dd7fc405e85 |
|---|
| 출처 메모 | uspto-grants-1976_08 |
|---|